Company: ARVN
Filing Date: 2025-03-11
Form Type: 8-K
Source: 0001655759-25-000057
Chunk: 3

Company: ARVINAS, INC.
Filing Date: 2025-03-11
Form: 8-K
Item: Item 8.01
Chunk 3
---
 filings.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements that involve substantial risks and uncertainties, including statements regarding overall survival data and future plans related to Phase 3 VERITAC-2 clinical trial data, including the plans related to sharing of data with global regulatory authorities to potentially support regulatory filings. All statements, other than statements of historical facts, contained in this Current Report on Form 8-K, including statements regarding the Company’s strategy, future operations, prospects, plans and objectives of management, are forward-looking statements. The word “plan,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements the Company makes as a result of various risks and uncertainties, including the important factors discussed the important factors discussed in the “ Risk Factors” sections contained in the Company’s quarterly and annual reports on file with the U. S. Securities and Exchange Commission. The forward-looking statements contained in this Current Report on Form 8-K reflect the Company’s current views with respect to future events, and the Company assumes no obligation to update any forward-looking statements except as required by applicable law. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.